aurobindo pharma - Robuta Search

https://kffhealthnews.org/morning-breakout/dr00034466/ Aurobindo Pharma Receives Tentative FDA Approval To Produce Pediatric Version of Generic... Aurobindo Pharma Receives Tentative FDA Approval To Produce Pediatric Version of Generic Antiretroviral Stavudine for PEPFAR aurobindo pharma fda approval https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aurobindo-pharma-limited-577033-02092023 Aurobindo Pharma Limited - 577033 - 02/09/2023 | FDA CGMP/Active Pharmaceutical Ingredient (API)/Adulterated aurobindo pharma limited 02 09 2023 fda https://www.ndtvprofit.com/markets/aurobindo-pharma-q2-result-profit-rises-9-missing-estimates-9969043 Aurobindo Pharma Q2 Result: Profit Rises 9%, Missing Estimates The Hyderabad-based bulk and generic drug maker's net profit increased 8% year-on-year to Rs 817 crore in the quarter ended Sept 30, 2024, according to an... aurobindo pharma q2 result profit rises https://www.ndtvprofit.com/business/aurobindo-pharma-arm-curateq-gets-health-canada-nod-for-biosimilar-11435266 Aurobindo Pharma Arm CuraTeQ Gets Health Canada Nod For Biosimilar Available in 100 mg and 400 mg formulations, the originator product Avastin is marketed by Roche/Genentech, filing added. aurobindo pharma health canada gets nod biosimilar https://www.aurobindo.com/ Aurobindo Pharma - Leading Global Pharmaceutical Company aurobindo pharma leading global pharmaceutical company https://www.business-standard.com/amp/markets/capital-market-news/itc-vedanta-aurobindo-pharma-in-focus-124031300127_1.html ITC, Vedanta, Aurobindo Pharma in focus | Capital Market News - Business Standard * Vedanta: SEBI ordered Vedanta to pay Rs 77.62 crore to Cairn for delayed dividend payments and barred its board from accessing the capital market. capital market news aurobindo pharma itc vedanta https://www.weforum.org/organizations/aurobindo-pharma/? Aurobindo Pharma | World Economic Forum Aurobindo Pharma is ranked among the top 10 generic pharma companies in the world. It is an integrated large global pharmaceutical company with a presence in... aurobindo pharma world economic forum https://www.business-standard.com/markets/aurobindo-pharma-ltd-share-price-4666/news Aurobindo Pharma Ltd News: Latest Aurobindo Pharma Ltd News Today on Business Standard Aurobindo Pharma Ltd News: Get the latest news today on Aurobindo Pharma Ltd. Follow Business Standard for the complete news coverage and key information about... aurobindo pharma news latest today on ltd business https://www.ndtvprofit.com/business/aurobindo-pharma-eyes-significant-portion-of-7-billion-osteoporosis-drug-market-9325783 Aurobindo Pharma Eyes 'Significant Portion' Of $7 Billion Osteoporosis Drug Market The company is preparing for regulatory filings in key markets like the US and EU starting January 2026. aurobindo pharma of 7 eyes significant portion https://www.business-standard.com/markets/capital-market-news/volumes-spurt-at-aurobindo-pharma-ltd-counter-124030200218_1.html Volumes spurt at Aurobindo Pharma Ltd counter | Capital Market News - Business Standard Aurobindo Pharma Ltd notched up volume of 21235 shares by 10:00 IST on BSE, a 0.6 fold spurt over two-week average daily volume of 35291 shares capital market news aurobindo pharma https://www.business-standard.com/amp/markets/capital-market-news/aurobindo-pharma-s-step-down-subsidiary-to-divest-its-entire-stake-in-jv-novagen-124100500172_1.html Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen' | Capital Market... Powered by Capital Market - Live News https://www.livemint.com/market/market-stats/stocks-aurobindo-pharma-share-price-nse-bse-s0003132 Aurobindo Pharma Share Price Today 15 May 2026: Live NSE/BSE Rates, Technical Analysis and Expert... Aurobindo Pharma Share Price Today 15 May 2026: Track Aurobindo Pharma share price today on NSE/BSE with real-time updates. Check stock performance,... https://www.business-standard.com/amp/markets/news/aurobindo-pharma-stock-news-analysts-are-bullish-despite-oai-to-eugia-unit-124052800402_1.html Aurobindo Pharma stock news: Analysts are bullish despite OAI to Eugia unit | News on Markets -... Analysts say that despite OAI on Eugia unit-III, Aurobindo Pharma's Vizag facility may play a back up for unit-III and for new ANDA filings contributing to... https://www.businesstoday.in/markets/stocks/story/aurobindo-pharma-lupin-sun-pharma-pharma-shares-rise-up-to-5-today-heres-why-497504-2025-10-09 Aurobindo Pharma, Lupin, Sun Pharma: Pharma shares rise up to 5% today, here's why - BusinessToday Oct 9, 2025 - Pharma shares rise: While Aurobindo Pharma shares rose 4.70% to Rs 1120.70, Cipla stock climbed 1.72% to Rs 1520.45 on BSE. https://www.fox10phoenix.com/news/certain-blood-pressure-tablets-under-voluntary-recall-from-aurobindo-pharma-usa-inc Certain blood pressure tablets under voluntary recall from Aurobindo Pharma USA, Inc. | FOX 10... A pharmaceutical company Aurobindo Pharma USA, Inc. has issued a voluntary recall of certain blood pressure tablets, because they may contain trace amounts of... https://www.republicworld.com/business/earnings-today-alert-general-insurance-corp-aurobindo-pharma-sundaram-finance-200-firms-set-to-report-q4-results Earnings Today Alert: General Insurance Corp, Aurobindo Pharma, Sundaram Finance & 200+ Firms Set... May 26, 2025 - The Indian stock market is poised for an action-packed day as over 200 companies are scheduled to announce their Q4 earnings. Key players like General... https://www.financialexpress.com/business/industry/aurobindo-pharma-buyback-rs-800-crore-plan-at-6-premium-check-key-dates-and-price-details/4214094/ Aurobindo Pharma Buyback: Rs 800 crore plan at 6% premium; Check key dates and price details -... Aurobindo Pharma announces Rs 800 crore share buyback at Rs 1,475 per share, a 6% premium. Check record date, opening date, closing timeline, and full details. https://www.businesstoday.in/markets/stocks/story/aurobindo-pharma-stock-in-focus-as-board-to-consider-share-buyback-on-thursday-july-18-437131-2024-07-15 Aurobindo Pharma stock in focus as board to consider share buyback on Thursday, July 18 -... Jul 15, 2024 - Aurobindo Pharma said its board meeting will be held on Thursday, July 18, 2024 to consider, inter alia, a proposal for buyback of the fully paid-up equity... https://www.businesstoday.in/markets/global-markets/story/is-pharma-back-on-growth-track-heres-why-axis-securities-is-betting-on-lupin-cipla-and-aurobindo-pharma-395260-2023-08-23 Is Pharma back on growth track? Here's why Axis Securities is betting on Lupin, Cipla and Aurobindo... Aug 23, 2023 - Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential. https://www.businesstoday.in/latest/economy/story/delhi-liquor-scam-will-disclose-details-after-internal-probe-says-aurobindo-pharma-after-promoters-arrest-352446-2022-11-10 Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after... Nov 10, 2022 - Earlier today, the ED arrested Reddy and Pernod Ricard general manager Benoy Babu under sections of the Prevention of Money Laundering Act (PMLA) in connection... delhi liquor scam https://www.business-standard.com/amp/companies/news/aurobindo-pharma-to-manufacture-supply-long-acting-hiv-treatment-drug-125071500477_1.html Aurobindo Pharma to manufacture, supply long acting HIV treatment drug | Company News - Business... Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. https://www.freepressjournal.in/business/aurobindo-pharma-to-make-hiv-long-acting-injection-supply-to-133-low-middle-income-countries Aurobindo Pharma To Make HIV Long-Acting Injection, Supply To 133 Low & Middle-Income Countries Aurobindo Pharma will manufacture and supply long-acting HIV treatment cabotegravir under a licensing agreement with MPP and ViiV Healthcare, expanding access... https://www.ndtvprofit.com/markets/corporate-actions-this-week-aurobindo-pharma-muthoot-finance-and-more-to-trade-ex-dividend-full-list-11343931 Corporate Actions This Week: Aurobindo Pharma, Muthoot Finance And More To Trade Ex-Dividend | Full... The listed companies have announced dividend payouts, income distribution, buy backs and stock splits that investors can benefit from. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aurobindo-pharma-usa-inc-initiates-voluntary-nationwide-consumer-level-recall-80-lots-amlodipine Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 80 Lots of... Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets... https://www.ktvu.com/news/certain-blood-pressure-tablets-under-voluntary-recall-from-aurobindo-pharma-usa-inc Certain blood pressure tablets under voluntary recall from Aurobindo Pharma USA, Inc. | KTVU FOX 2 A pharmaceutical company Aurobindo Pharma USA, Inc. has issued a voluntary recall of certain blood pressure tablets, because they may contain trace amounts of... https://www.business-standard.com/markets/capital-market-news/aurobindo-pharma-ltd-rises-for-third-consecutive-session-124042900353_1.html Aurobindo Pharma Ltd rises for third consecutive session | Capital Market News - Business Standard Aurobindo Pharma Ltd is quoting at Rs 1151.5, up 1.79% on the day as on 12:49 IST on the NSE. The stock is up 86.54% in last one year as compared to a 24.35%... https://www.businesstoday.in/markets/stock-picks/story/sbi-life-hero-motocorp-aurobindo-pharma-ril-what-mileen-vasudeo-of-arihant-capital-says-on-these-4-stocks-406635-2023-11-22 SBI Life, Hero MotoCorp, Aurobindo Pharma & RIL: What Mileen Vasudeo of Arihant Capital says on... Nov 22, 2023 - Top stock picks for today: In an interaction with BT TV, Mileen Vasudeo said SBI Life Insurance Company Ltd's share price could head higher in the near term.... https://www.ndtvprofit.com/markets/aurobindo-pharma-announces-rs-800-crore-share-buyback-check-record-date-price-other-details-11387828 Aurobindo Pharma Announces Rs 800-Crore Share Buyback; Check Record Date, Price, Other Details Aurobindo Pharma will repurchase around 54 lakh shares at Rs 1,475 apiece, and the record date has been fixed as April 17. https://www.business-standard.com/amp/markets/capital-market-news/aurobindo-pharma-ltd-rises-for-third-straight-session-125012000561_1.html Aurobindo Pharma Ltd rises for third straight session | Capital Market News - Business Standard Aurobindo Pharma Ltd is quoting at Rs 1197.8, up 1.65% on the day as on 12:49 IST on the NSE. The stock is up 5.66% in last one year as compared to a 9.94%...